Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe osteopenia in CFTR-null mice.

Fariel Dif1, Caroline Marty, Claude Baudoin

  • 1UMR5166 CNRS-MNHN, Evolution des Régulations Endocriniennes, 75231 Paris Cedex 5, France.

Bone
|September 1, 2004
PubMed
Summary

Cystic fibrosis (CF) patients often develop osteoporosis. This study in a CF mouse model shows the CFTR mutation causes severe bone loss, reduced bone formation, and increased resorption, confirming it as a syndromic symptom.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR T cell therapy selectively depletes disease-driving mutant calreticulin cells in xenotransplants and human organoid models of myelofibrosis.

Science translational medicine·2026
Same author

Increased Osteoclast Activity Contributes to Bone Resorption and Osteopenia in a Rett Syndrome Mouse Model.

Cells·2026
Same author

Unraveling the role of <i>TP53</i> mutations in myeloproliferative neoplasms: Molecular mechanisms of leukemic transformation.

HemaSphere·2026
Same author

MCM8- and MCM9 Deficiencies Cause Lifelong Increased Hematopoietic DNA Damage Driving p53-Dependent Myeloid Tumors.

Cell reports·2025
Same author

Dissecting JAK2V617F's double life with and without MPL.

Blood·2025
Same author

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nature communications·2025

Area of Science:

  • Bone Biology
  • Genetics
  • Pathophysiology

Background:

  • Osteoporosis is a frequent complication in cystic fibrosis (CF) patients.
  • The underlying mechanisms of CF-associated bone disease are not fully understood.

Purpose of the Study:

  • To investigate the impact of the cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation on bone structure and remodeling.
  • To analyze bone histomorphometry in a genetic mouse model of human CF.

Main Methods:

  • Histomorphometric analysis of bone tissue.
  • Utilized a genetic mouse model with inactivated CFTR gene copies.
  • Assessed bone mineral density (BMD), cortical bone width, trabecular thickness, and dynamic bone parameters.

Main Results:

Related Experiment Videos

  • CFTR mutation is associated with severe osteopenia and significantly diminished BMD.
  • Demonstrated a 50% reduction in cortical bone width and thinner trabeculae in CFTR mutants.
  • Observed a significant decrease in bone formation and a marked increase in bone resorption, with increased osteoclast activity.

Conclusions:

  • The CFTR mutation directly contributes to severe bone loss in cystic fibrosis.
  • CF-associated osteoporosis is an intrinsic syndromic symptom of the CFTR mutation.
  • Findings highlight the role of CFTR in maintaining bone health.